Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06624956 · ClinicalTrials.gov registry record · Phase 4
Prevention and Treatment of Common Hyperglycemia in Surgery Pilot
A Phase 4 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 106
- Enrollment target
NCT06624956 is a Phase 4 study that has completed, run by University of Washington. The registered enrollment target is 106 participants.
The verdict
NCT06624956, a Phase 4 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 106 participants
- Enrollment target
Study Summary
The PATCH pilot trial aims to establish feasibility and determine the sample size of a future, large-scale, multi-site RCT, as well as reinforce the long-standing known safety profile of glucose, insulin, and potassium (GIK) and explore the physiologic response. We hypothesize that the use of GIK in non-diabetic patients undergoing abdominal surgery, will reduce rates of morbidity \& death compared to standard of care treatment. In brief, primary outcomes of interest include estimation of the standard deviation (to derive a sample size estimation) and the ability to recruit target population, assessment of patient compliance/burden, and assessment of provider compliance/burden (feasibility).
Interventions
- DRUG glucose, insulin, and potassium (GIK)
- DRUG Crystalloid Infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2024-09-04 |
| Est. Completion | 2026-01-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06624956
The ClinicalTrials.gov registry entry for NCT06624956 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which glucose, insulin, and potassium (GIK) is the first listed.
NCT06624956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06624956 about?
NCT06624956 is a clinical study titled "Prevention and Treatment of Common Hyperglycemia in Surgery Pilot". The PATCH pilot trial aims to establish feasibility and determine the sample size of a future, large-scale, multi-site RCT, as well as reinforce the long-standing known safety profile of glucose, insulin, and potassium (GIK) and explore the physiologic response. We hypothesize that the use of GIK in...
What is the current status of trial NCT06624956?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 106 participants. The study started on 2024-09-04. Estimated completion is 2026-01-01.
What interventions are being tested in trial NCT06624956?
The interventions under investigation include: glucose, insulin, and potassium (GIK) (DRUG), Crystalloid Infusion (DRUG).
Who is sponsoring clinical trial NCT06624956?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.